Bruker Spatial Genomics,

Acuity Spatial Genomics, Inc. provides a ground-breaking platform designed for simultaneous, genome-wide visualization of the 3D genome in single cells and opens new frontiers in spatial multiomic analyses for discovery. Based on patented technologies developed at Harvard University, the company’s OligoFISSEQ and OligoFISSEQ HD technologies empower researchers to visualize the genome organization and 3D chromatin architecture of individual cells, directly in situ, and in an accessible time-to-result and cost-effective approach. The Acuity technology platform enables the possibility to delve deeper and gain critical insight into transcription regulatory programs that drive cell type, state, function, and pathogenesis—and thus advance discovery in areas such as oncology, neuroscience, and disease research. The company has facilities in Massachusetts and California.